Mandate

Vinge advises SJ in connection with agreement governing restoration of SJ 2000 trains

January 16, 2014

SJ is making one of the largest commitments in the company’s 150-year history by investing in a comprehensive renewal and restoration programme for its fleet of SJ 2000 trains. SJ has entered into an agreement with ABB concerning the initial technical restoration of the entire fleet of SJ 2000 trains (previously X 2000). This phase of the renovation will cost approximately SEK 1.4 billion. The first newly-renovated SJ 2000 train will be put into operation in 2016, although the renewal and restoration programme will continue until 2019. The renovation is anticipated to reduce energy consumption by approximately 10 per cent.

Vinge’s team consisted of, among others, partners Eva Fredrikson and Björn Gustavsson and associate Mikael Satama Grönberg.   

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026